EyePoint Pharmaceuticals Inc. buy Capital One Financial Co.
Start price
11.12.23
/
50%
€18.40
Target price
11.12.24
€40.94
Performance (%)
-56.86%
End price
12.12.24
€7.94
Summary
This prediction ended on 12.12.24 with a price of €7.94. The BUY prediction by Capital_One_Financia for EyePoint Pharmaceuticals Inc. performed very badly with a performance of -56.86%. Capital_One_Financia has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | 9.339% | 9.339% | 85.190% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by Capital_One_Financia for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is now covered by analysts at Capital One Financial Co.. They set an "overweight" rating and a $44.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von Capital_One_Financia gewählte maximale Laufzeit wurde überschritten